Real-world efficacy of nivolumab plus ipilimumab combination therapy versus nivolumab monotherapy for Stage IV melanoma patients in Asia

被引：0
|
作者：
Takuya Maeda
Azusa Hiura
Jiro Uehara
Rino Toyoshima
Tomoe Nakagawa
Koji Yoshino
机构：
[1] Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital,Department of Dermatologic Oncology
来源：
European Journal of Dermatology | 2021年 / 31卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：662 / 664
页数：2
相关论文
共 50 条
  • [21] Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
    Weber, J.
    Mandala, M.
    Del Vecchio, M.
    Gogas, H. J.
    Arance, A. M.
    Cowey, C. L.
    Dalle, S.
    Schenker, M.
    Chiarion-Sileni, V.
    Marquez-Rodas, I.
    Grob, J-J.
    Butler, M. O.
    Middleton, M. R.
    Maio, M.
    Atkinson, V.
    Queirolo, P.
    Gonzalez, R.
    Kudchadkar, R. R.
    Smylie, M.
    Meyer, N.
    Mortier, L.
    Atkins, M. B.
    Long, G. V.
    Bhatia, S.
    Lebbe, C.
    Rutkowski, P.
    Yokota, K.
    Yamazaki, N.
    Kim, T. M.
    de Pril, V.
    Sabater, J.
    Qureshi, A.
    Larkin, J.
    Ascierto, P. A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (19): : 1824 - 1835
  • [22] Nivolumab and ipilimumab in the real-world setting in patients with mesothelioma
    Dumoulin, D. W.
    Douma, L. H.
    Hofman, M. M.
    van der Noort, V.
    Cornelissen, R.
    de Gooijer, C. J.
    Burgers, J. A.
    Aerts, J. G. J. V.
    LUNG CANCER, 2024, 187
  • [23] Real-world Data on advanced Melanoma: First Data from a national, prospective, non-interventional Study of Nivolumab in Combination with Ipilimumab or as Nivolumab Monotherapy (NICO)
    Weichenthal, M.
    Gutzmer, R.
    Eigentler, T.
    Mohr, P.
    Goeppner, D.
    Haferkamp, S.
    Herber, M.
    Herbst, R.
    Meier, F.
    Meiss, F.
    Pfoehler, C.
    Schneider, S. W.
    Terheyden, P.
    Ulrich, J.
    Utikal, J.
    Weishaupt, C.
    Welzel, J.
    Schadendorf, D.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 5 - 6
  • [24] Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915)
    Weber, Jeffrey S.
    Schadendorf, Dirk
    Del Vecchio, Michele
    Larkin, James
    Atkinson, Victoria
    Schenker, Michael
    Pigozzo, Jacopo
    Gogas, Helen
    Dalle, Stephane
    Meyer, Nicolas
    Ascierto, Paolo A.
    Sandhu, Shahneen
    Eigentler, Thomas
    Gutzmer, Ralf
    Hassel, Jessica C.
    Robert, Caroline
    Carlino, Matteo S.
    Di Giacomo, Anna Maria
    Butler, Marcus O.
    Munoz-Couselo, Eva
    Brown, Michael P.
    Rutkowski, Piotr
    Haydon, Andrew
    Grob, Jean-Jacques
    Schachter, Jacob
    Queirolo, Paola
    de la Cruz-Merino, Luis
    Haydon, Andrew
    Grob, Jean-Jacques
    Schachter, Jacob
    Queirolo, Paola
    De La Cruz-Merino, Luis
    van der Westhuizen, Andre
    Menzies, Alexander M.
    Re, Sandra
    Bas, Tuba
    de Pril, Veerle
    Braverman, Julia
    Tenney, Daniel J.
    Tang, Hao
    Long, Georgina, V
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (03) : 517 - +
  • [25] Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma
    Wolchok, Jedd D.
    Chiarion-Sileni, Vanna
    Gonzalez, Rene
    Grob, Jean-Jacques
    Rutkowski, Piotr
    Lao, Christopher D.
    Cowey, C. Lance
    Schadendorf, Dirk
    Wagstaff, John
    Dummer, Reinhard
    Ferrucci, Pier Francesco
    Smylie, Michael
    Butler, Marcus O.
    Hill, Andrew
    Marquez-Rodas, Ivan
    Haanen, John B. A. G.
    Guidoboni, Massimo
    Maio, Michele
    Schoffski, Patrick
    Carlino, Matteo S.
    Lebbe, Celeste
    McArthur, Grant
    Ascierto, Paolo A.
    Daniels, Gregory A.
    Long, Georgina, V
    Bas, Tuba
    Ritchings, Corey
    Larkin, James
    Hodi, F. Stephen
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (02) : 127 - +
  • [26] Immunotherapy with ipilimumab plus nivolumab in a stage IV melanoma patient during pregnancy
    Menzer, Christian
    Beedgen, Bernd
    Rom, Joachim
    Duffert, Christin M.
    Volckmar, Anna-Lena
    Sedlaczek, Oliver
    Richtig, Erika
    Enk, Alexander
    Jaeger, Dirk
    Hassel, Jessica C.
    EUROPEAN JOURNAL OF CANCER, 2018, 104 : 239 - 242
  • [27] Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic Melanoma
    Asher, Nethanel
    Ben-Betzalel, Guy
    Lev-Ari, Shaked
    Shapira-Frommer, Ronnie
    Steinberg-Silman, Yael
    Gochman, Neta
    Schachter, Jacob
    Meirson, Tomer
    Markel, Gal
    CANCERS, 2020, 12 (08) : 1 - 18
  • [28] Japanese real-world study of sequential nivolumab and ipilimumab treament in melanoma
    Tsutsumida, Arata
    Fukushima, Satoshi
    Yokota, Kenji
    Yoshikawa, Shusuke
    Yamasaki, Osamu
    Tanemura, Atsushi
    Okuyama, Ryuhei
    Uhara, Hisashi
    Muto, Yusuke
    Miyashita, Azusa
    Akiyama, Masashi
    Kaji, Tatsuya
    Koga, Hiroshi
    Kato, Junji
    Katayama, Teruaki
    Itakura, Eijun
    Yamazaki, Naoya
    Kiyohara, Yoshio
    JOURNAL OF DERMATOLOGY, 2019, 46 (11): : 947 - 955
  • [29] PKPD relationship of ipilimumab plus nivolumab combination in patients with advanced melanoma
    Goldwirt, L.
    Louveau, B.
    Liv, T.
    Baroudjian, B.
    Allayous, C.
    Da Meda, L.
    Delyon, J.
    Sauvageon, H.
    Lebbe, C.
    Mourah, S.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 38 - 38
  • [30] Gastrointestinal complications in patients treated with ipilimumab and nivolumab combination therapy or monotherapy
    Irwin, Debra E.
    Davis, Brian
    Bell, Jill A.
    Galaznik, Aaron
    Garcia-Ribas, Ignacio
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (02) : 81 - 90
12345